NurExone Biologic Inc. (J90)
Market Closed
3 Jun, 20:00
€
0. 3560
-0.016
-4.3%
€
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
€ 0.372
Previous Close Want to track J90 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
NurExone Biologic Inc. (J90) Statistics
Valuation metrics
Market Cap -
Enterprise value -2.03M
Trailing P/E (ttm) -
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) -
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.33
Overview
Shares outstanding 90.68M
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 6
Average volume (90 days) 2
Price summary
52-Week low 0.32
52-Week high 0.68
Beta -
50-Day moving average 0.38
200-Day moving average 0.44
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.56%
Return on equity -2.31%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -6.38M
Diluted EPS (ttm) -
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 136K
Total cash per share (mrq) -
Total debt (mrq) 108K
Total Debt/Equity (mrq) 0.04
Current ratio (mrq) 2.63%
Book value per share (mrq) -
Cash Flow
Cash flow statement -4.59M
Levered free cash flow (LFCF) -6.38M
